Literature DB >> 16805525

Physanolide A, a novel skeleton steroid, and other cytotoxic principles from Physalis angulata.

Ping-Chung Kuo1, Tsung-Hsiao Kuo, Amooru G Damu, Chung-Ren Su, E-Jian Lee, Tian-Shung Wu, Rexen Shu, Chou-Ming Chen, Kenneth F Bastow, Tzu-Hsuan Chen, Kuo-Hsiung Lee.   

Abstract

[reaction: see text] A novel withasteroid, physanolide A (1), with an unprecedented skeleton containing a seven-membered ring, and two new physalins, physalins U (2) and V (3), were isolated from Physalis angulata. The structures were elucidated from spectroscopic analysis, and plausible biosynthetic pathways were postulated. Physalins B (4), D (5), and F (6) showed strong cytotoxicity against multiple tumor cell lines, including KB, A431, HCT-8, PC-3, and ZR751, with EC(50) values less than 4 microg/mL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16805525     DOI: 10.1021/ol060801s

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Physalin F induces cell apoptosis in human renal carcinoma cells by targeting NF-kappaB and generating reactive oxygen species.

Authors:  Szu-Ying Wu; Yann-Lii Leu; Ya-Ling Chang; Tian-Shung Wu; Ping-Chung Kuo; Yu-Ren Liao; Che-Ming Teng; Shiow-Lin Pan
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

2.  Synthesis of the Right-Side Structure of Type B Physalins.

Authors:  Masaki Morita; Shuntaro Kojima; Megumi Ohkubo; Hiroyuki Koshino; Daisuke Hashizume; Go Hirai; Keiji Maruoka; Mikiko Sodeoka
Journal:  Isr J Chem       Date:  2016-11-09       Impact factor: 3.333

Review 3.  Traditional and Phytochemical Bases of Herbs, Shrubs, Climbers, and Trees from Ethiopia for Their Anticancer Response.

Authors:  Limenew Abate; Mesfin Getachew Tadesse; Archana Bachheti; Rakesh Kumar Bachheti
Journal:  Biomed Res Int       Date:  2022-02-03       Impact factor: 3.411

Review 4.  Antitumor Profile of Carbon-Bridged Steroids (CBS) and Triterpenoids.

Authors:  Valery M Dembitsky; Tatyana A Gloriozova; Vladimir V Poroikov
Journal:  Mar Drugs       Date:  2021-06-03       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.